Published in Gastroenterology on December 01, 1992
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut (1996) 2.40
Prioritization and organ distribution for liver transplantation. JAMA (1994) 2.38
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet (1993) 1.21
Primary sclerosing cholangitis. Can J Gastroenterol (2008) 1.17
Disease gravity and urgency of need as guidelines for liver allocation. Hepatology (1994) 1.16
Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population. Gut (2002) 1.08
Primary sclerosing cholangitis: overview and update. Nat Rev Gastroenterol Hepatol (2010) 1.08
Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis. Gut (2002) 1.05
Oral nicotine in treatment of primary sclerosing cholangitis: a pilot study. Dig Dis Sci (1999) 1.05
Primary sclerosing cholangitis: diagnosis, prognosis, and management. Clin Gastroenterol Hepatol (2013) 0.98
Clinical features and management of primary sclerosing cholangitis. World J Gastroenterol (2008) 0.94
Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease. J Crohns Colitis (2014) 0.91
K-ras mutations in the bile of patients with primary sclerosing cholangitis. Gut (2001) 0.90
The overlap syndromes of autoimmune hepatitis. Dig Dis Sci (2012) 0.86
Indications for referral and assessment in adult liver transplantation: a clinical guideline. British Society of Gastroenterology. Gut (1999) 0.85
Primary sclerosing cholangitis: resect, dilate, or transplant? Ann Surg (1998) 0.85
Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis. Int J Colorectal Dis (2009) 0.81
Analytical review of diagnosis and treatment strategies for dominant bile duct strictures in patients with primary sclerosing cholangitis. HPB (Oxford) (2011) 0.81
Pirfenidone in the treatment of primary sclerosing cholangitis. Dig Dis Sci (2002) 0.81
Steroid-responsive (autoimmune?) sclerosing cholangitis. Dig Dis Sci (2005) 0.81
Role of endoscopic retrograde cholangiopancreatography in the management of benign biliary strictures: What's new? World J Gastrointest Endosc (2016) 0.79
Hepatic retransplantation in cholestatic liver disease: impact of the interval to retransplantation on survival and resource utilization. Hepatology (1999) 0.78
Liver transplantation(). J Ultrasound (2007) 0.77
Liver disease. Postgrad Med J (1994) 0.76
Controversies in the management of primary sclerosing cholangitis. World J Hepatol (2016) 0.76
Waiting list mortality of patients with primary biliary cirrhosis in the Japanese transplant allocation system. J Gastroenterol (2013) 0.76
A review of the medical treatment of primary sclerosing cholangitis in the 21st century. Ther Adv Chronic Dis (2016) 0.75
Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. Kusuri No Chishiki (1995) 0.75
Benign Biliary Strictures. Semin Intervent Radiol (2016) 0.75
Update in liver transplantation. Can Fam Physician (1999) 0.75
Evaluation of Biliary Calprotectin as a Biomarker in Primary Sclerosing Cholangitis. Medicine (Baltimore) (2016) 0.75
Asymptomatic primary sclerosing cholangitis with marked hepatic fibrosis. Dig Dis Sci (2000) 0.75
A multiple testing procedure for clinical trials. Biometrics (1979) 26.80
A model to predict survival in patients with end-stage liver disease. Hepatology (2001) 18.06
Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. N Engl J Med (1990) 11.57
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol (1999) 9.11
Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc (1980) 8.36
Evaluation of abnormal liver-enzyme results in asymptomatic patients. N Engl J Med (2000) 7.97
Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA (1992) 6.99
One-sample multiple testing procedure for phase II clinical trials. Biometrics (1982) 6.45
Biliary tract cancers. N Engl J Med (1999) 6.36
An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA (1993) 5.43
Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol (1995) 4.68
Estimating the proportion of treatment effect explained by a surrogate marker. Stat Med (1997) 4.64
Evidence for the natural transmission of influenza A virus from wild ducts to swine and its potential importance for man. Bull World Health Organ (1981) 4.20
Increased expression of CD44v6 and CD44v3 in ulcerative colitis but not colonic Crohn's disease. Lancet (1995) 4.12
Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology. Gut (1980) 4.09
Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. J Clin Oncol (1989) 4.03
Pathogenesis and treatment of gallstones. N Engl J Med (1993) 3.99
Prognosis in primary biliary cirrhosis: model for decision making. Hepatology (1989) 3.83
Fluorouracil plus levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med (1995) 3.83
MELD and PELD: application of survival models to liver allocation. Liver Transpl (2001) 3.76
Clinicopathologic features of the syndrome of primary sclerosing cholangitis. Gastroenterology (1980) 3.57
Designs for group sequential tests. Control Clin Trials (1984) 3.56
High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy. A randomized double-blind comparison. N Engl J Med (1985) 3.36
Intracellular anions as the voltage sensor of prestin, the outer hair cell motor protein. Science (2001) 2.99
Surgery for recurrent colon cancer: strategies for identifying resectable recurrence and success rates after resection. Eastern Cooperative Oncology Group, the North Central Cancer Treatment Group, and the Southwest Oncology Group. Ann Intern Med (1998) 2.95
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78
Relationships between circulating and intracellular thyroid hormones: physiological and clinical implications. Endocr Rev (1981) 2.78
Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology (1998) 2.75
Effect of polyions on the infectivity of rabies virus in tissue culture: construction of a single-cycle growth curve. J Virol (1967) 2.67
Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol (1978) 2.63
Weighted Kaplan-Meier statistics: a class of distance tests for censored survival data. Biometrics (1989) 2.51
Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy. Gastroenterology (1996) 2.48
Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology (1978) 2.41
Primary sclerosing cholangitis: natural history, prognostic factors and survival analysis. Hepatology (1989) 2.39
Cap polyposis--an unusual cause of diarrhoea. Gut (1993) 2.38
Inflammatory cytokines induce DNA damage and inhibit DNA repair in cholangiocarcinoma cells by a nitric oxide-dependent mechanism. Cancer Res (2000) 2.38
Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med (1997) 2.38
Current concepts. Primary sclerosing cholangitis. N Engl J Med (1984) 2.35
Pulmonary hemodynamics and perioperative cardiopulmonary-related mortality in patients with portopulmonary hypertension undergoing liver transplantation. Liver Transpl (2000) 2.27
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study. J Clin Oncol (1995) 2.26
The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol (2000) 2.25
Surrogate end points, health outcomes, and the drug-approval process for the treatment of risk factors for cardiovascular disease. JAMA (1999) 2.21
Diagnostic plots to reveal functional form for covariates in multiplicative intensity models. Biometrics (1995) 2.19
The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients. Hepatology (1989) 2.19
Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Liver Transpl Surg (1997) 2.16
The long-term pathological evolution of chronic hepatitis C. Hepatology (1996) 2.15
Mixed cryoglobulinemia responsive to interferon-alpha. Am J Med (1991) 2.15
Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma. Obstet Gynecol (1982) 2.12
The SGOT/SGPT ratio--an indicator of alcoholic liver disease. Dig Dis Sci (1979) 2.12
The pancreas in primary biliary cirrhosis and primary sclerosing cholangitis. Gastroenterology (1982) 2.11
Epidemiology of rabies. Nature (1969) 2.11
Ursodeoxycholic acid in the treatment of primary biliary cirrhosis. Gastroenterology (1994) 2.10
Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis. Gastroenterology (1991) 2.06
Primary biliary cirrhosis. N Engl J Med (1987) 2.06
Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. Cardiovasc Res (2001) 2.05
Optimists vs pessimists: survival rate among medical patients over a 30-year period. Mayo Clin Proc (2000) 2.02
Intergroup study of fluorouracil plus levamisole as adjuvant therapy for stage II/Dukes' B2 colon cancer. J Clin Oncol (1995) 2.02
Intrapulmonary vascular dilatations (IPVD) in liver transplant candidates. Screening by two-dimensional contrast-enhanced echocardiography. Chest (1990) 1.99
Monokine-induced synthesis of serum amyloid A protein by hepatocytes. Nature (1980) 1.97
Liver disease associated with early syphilis. N Engl J Med (1971) 1.95
Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg (1999) 1.94
Efficiency of liver transplantation in patients with primary biliary cirrhosis. N Engl J Med (1989) 1.94
Primary sclerosing cholangitis. N Engl J Med (1995) 1.94
A new route to nucleoside 5'-triphosphates. Acta Biochim Biophys Acad Sci Hung (1981) 1.93
Incidence, distribution, and outcome of episodes of infection in 100 orthotopic liver transplantations. Mayo Clin Proc (1989) 1.93
The epidemiology of influenza. Sci Am (1977) 1.90
Models of mitochondrial DNA transmission genetics and evolution in higher eucaryotes. Genet Res (1982) 1.89
Isolation and morphologic characterization of bile duct epithelial cells from normal rat liver. Gastroenterology (1989) 1.89
Morphologic features of chronic hepatitis associated with primary sclerosing cholangitis and chronic ulcerative colitis. Hepatology (1982) 1.88
Hepatic processing of transforming growth factor beta in the rat. Uptake, metabolism, and biliary excretion. J Clin Invest (1987) 1.88
Effects of ursodeoxycholic acid on survival in patients with primary biliary cirrhosis. Gastroenterology (1996) 1.87
Impact of pegylated interferon and ribavirin treatment on graft survival in liver transplant patients with recurrent hepatitis C infection. Am J Transplant (2008) 1.86
pH gating of ROMK (K(ir)1.1) channels: control by an Arg-Lys-Arg triad disrupted in antenatal Bartter syndrome. Proc Natl Acad Sci U S A (1999) 1.85
A letter to the next speaker. Mayo Clin Proc (1973) 1.85
Lumbar epidural perineural injection: a new technique. Eur Spine J (1997) 1.85
Effective protection of monkeys against death from street virus by post-exposure administration of tissue-culture rabies vaccine. Bull World Health Organ (1971) 1.85
Monooctanoin, a dissolution agent for retained cholesterol bile duct stones: physical properties and clinical application. Gastroenterology (1980) 1.84
Variant forms of cholestatic diseases involving small bile ducts in adults. Am J Gastroenterol (2000) 1.83
Hypothyroidism after treatment with interleukin-2 and lymphokine-activated killer cells. N Engl J Med (1988) 1.82
Reaction of bone to methacrylate after hip arthroplasty: a long-term gross, light microscopic, and scanning electron microscopic study. J Bone Joint Surg Am (1974) 1.81
A controlled trial of cyclosporine in the treatment of primary biliary cirrhosis. N Engl J Med (1990) 1.81
Serum ferritin and the iron status of Canadians. Can Med Assoc J (1976) 1.79
Association of primary sclerosing cholangitis with HLA-B8. Gut (1983) 1.79
Cholangiocarcinoma complicating primary sclerosing cholangitis. Ann Surg (1991) 1.78